Market Overview – Swiss Equities on 4 August 2026

The Swiss market closed marginally higher on 4 August 2026, with the benchmark Swiss Market Index (SMI) recording a modest gain. The day’s performance reflected a combination of easing geopolitical concerns and a sharp decline in oil prices, which helped maintain a broadly positive market sentiment.

Individual Stock Movements

  • Galderma Group (German‑owned dermatology specialist) experienced a decline of approximately one percent, despite the overall market rally.
  • Logitech International and Sonova posted gains of close to four percent each, underscoring strength in the technology and medical devices sectors.

These movements illustrate the heterogeneous nature of the Swiss equity landscape, where individual company dynamics can diverge from broader market trends.

Upcoming SMI Composition Changes

A notice from Dow Jones Newswires, released the following day, detailed index rebalancing set for 21 September 2026. The changes include:

  • Addition of Galderma Group to the SMI, indicating that the company has achieved the performance and market presence necessary to join the core constituents of the Swiss benchmark.
  • Removal of Kühne + Nagel (Swiss logistics firm) and Swisscom (telecommunications) from the index.

The inclusion of Galderma reflects a shift in the composition of the Swiss market’s leading companies, highlighting a greater representation of the healthcare and specialty pharmaceuticals sectors within the SMI.

Macroeconomic Context

Data from Switzerland’s Federal Statistical Office provide important context for the market’s recent performance:

  • Consumer Price Inflation: The annual consumer price index (CPI) rose by roughly 0.4 percent in July, marking the lowest increase in four months.
  • Core Inflation: Excluding unprocessed food and energy, core inflation remained steady at around 0.3 percent on an annual basis.

These figures suggest a softening of inflationary pressures. Lower inflation can influence expectations for corporate earnings, potentially easing concerns about margin compression and supporting valuations. The combination of modest inflation and reduced oil prices may further bolster investor confidence.

Strategic Implications

Galderma’s entry into the SMI signals its growing prominence within the Swiss equity market and positions the company as a more influential player in shaping index performance. This development may attract index‑tracking funds and increase liquidity for Galderma shares.

For other SMI constituents, the removal of Kühne + Nagel and Swisscom reflects a reallocation of weight toward sectors perceived to offer stronger growth prospects, such as technology and healthcare. Investors monitoring sectoral shifts should therefore pay close attention to how these changes influence portfolio construction and risk exposure.

Conclusion

The Swiss market’s modest rise on 4 August 2026, coupled with Galderma Group’s impending inclusion in the SMI and the Federal Statistical Office’s inflation data, paints a picture of a cautiously optimistic investment environment. While individual company performance remains variable, macroeconomic indicators point to easing inflation and stable commodity prices—factors that may underpin future corporate earnings and valuation dynamics across the Swiss equity landscape.